Clinical Trial: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07283263) titled 'A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.' on Dec. 02.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, and drug levels of BMS-986521 following single and multiple ascending doses of BMS-986521in healthy adult participants, and to evaluate potential food effects on BMS-986521 exposure.

Study Start Date: Dec. 24

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: BMS-985521

Specified dose on specified days.

OTHER: Placebo

Specified dose on specified days

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bristo...